Qureight utilizes AI and data curation to expedite drug development, focusing on lung and heart diseases. By collaborating with pharmaceutical companies, contract research organizations, and hospitals, it optimizes clinical trial processes through intelligent data analysis and integration. Their technology uncovers critical insights from complex trial data, enhancing decision-making and accelerating the approval of life-saving drugs.
📋 Overview of Qureight
📙 About Qureight
💰 Recent Investors of Qureight
Cambridge Angels, Guinness Ventures, Investor
© 2025 Bot Memo. All Rights Reserved.
